These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26911756)

  • 1. US cancer institute to overhaul tumour cell lines.
    Ledford H
    Nature; 2016 Feb; 530(7591):391. PubMed ID: 26911756
    [No Abstract]   [Full Text] [Related]  

  • 2. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
    Coyne GO; Takebe N; Chen AP
    Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.
    Kondo J; Inoue M
    Cells; 2019 May; 8(5):. PubMed ID: 31108870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
    Kong D; Yamori T
    Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novartis Compiles Mouse Avatar "Encyclopedia".
    Poh A
    Cancer Discov; 2016 Jan; 6(1):5-6. PubMed ID: 26621761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
    Barretina J; Caponigro G; Stransky N; Venkatesan K; Margolin AA; Kim S; Wilson CJ; Lehár J; Kryukov GV; Sonkin D; Reddy A; Liu M; Murray L; Berger MF; Monahan JE; Morais P; Meltzer J; Korejwa A; Jané-Valbuena J; Mapa FA; Thibault J; Bric-Furlong E; Raman P; Shipway A; Engels IH; Cheng J; Yu GK; Yu J; Aspesi P; de Silva M; Jagtap K; Jones MD; Wang L; Hatton C; Palescandolo E; Gupta S; Mahan S; Sougnez C; Onofrio RC; Liefeld T; MacConaill L; Winckler W; Reich M; Li N; Mesirov JP; Gabriel SB; Getz G; Ardlie K; Chan V; Myer VE; Weber BL; Porter J; Warmuth M; Finan P; Harris JL; Meyerson M; Golub TR; Morrissey MP; Sellers WR; Schlegel R; Garraway LA
    Nature; 2012 Mar; 483(7391):603-7. PubMed ID: 22460905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology Developing First Clinical Trial.
    Brower V
    J Natl Cancer Inst; 2015 Nov; 107(11):djv356. PubMed ID: 26538625
    [No Abstract]   [Full Text] [Related]  

  • 8. Organoid development in cancer genome discovery.
    Gao D; Chen Y
    Curr Opin Genet Dev; 2015 Feb; 30():42-8. PubMed ID: 25796043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What role could organoids play in the personalization of cancer treatment?
    Francies HE; Garnett MJ
    Pharmacogenomics; 2015; 16(14):1523-6. PubMed ID: 26485224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microfluidics platform for combinatorial drug screening on cancer biopsies.
    Eduati F; Utharala R; Madhavan D; Neumann UP; Longerich T; Cramer T; Saez-Rodriguez J; Merten CA
    Nat Commun; 2018 Jun; 9(1):2434. PubMed ID: 29934552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting and affecting response to cancer therapy based on pathway-level biomarkers.
    Ben-Hamo R; Jacob Berger A; Gavert N; Miller M; Pines G; Oren R; Pikarsky E; Benes CH; Neuman T; Zwang Y; Efroni S; Getz G; Straussman R
    Nat Commun; 2020 Jul; 11(1):3296. PubMed ID: 32620799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug sensitivity testing platforms for gastric cancer diagnostics.
    Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
    J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug screening on digital microfluidics for cancer precision medicine.
    Zhai J; Liu Y; Ji W; Huang X; Wang P; Li Y; Li H; Wong AH; Zhou X; Chen P; Wang L; Yang N; Chen C; Chen H; Mak PI; Deng CX; Martins R; Yang M; Ho TY; Yi S; Yao H; Jia Y
    Nat Commun; 2024 May; 15(1):4363. PubMed ID: 38778087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mining the NCI screening database: explorations of agents involved in cell cycle regulation.
    Wallqvist A; Monks A; Rabow AA; Thanki N; Shoemaker RH; Covell DG
    Prog Cell Cycle Res; 2003; 5():173-9. PubMed ID: 14593711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on NCI in vitro drug screen utilities.
    Holbeck SL
    Eur J Cancer; 2004 Apr; 40(6):785-93. PubMed ID: 15120034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer: Authenticate new xenograft models.
    Nardone RM; MacLeod RA; Capes-Davis A
    Nature; 2016 Apr; 532(7599):313. PubMed ID: 27127813
    [No Abstract]   [Full Text] [Related]  

  • 17. Perspectives on research activity in the USA on Cancer Precision Medicine.
    Bando H; Takebe N
    Jpn J Clin Oncol; 2016 Feb; 46(2):106-10. PubMed ID: 26531706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mice with human tumours: Growing pains for a popular cancer model.
    Willyard C
    Nature; 2018 Aug; 560(7717):156-157. PubMed ID: 30087485
    [No Abstract]   [Full Text] [Related]  

  • 20. National Cancer Institute Basket/Umbrella Clinical Trials: MATCH, LungMAP, and Beyond.
    Chen AP; Eljanne M; Harris L; Malik S; Seibel NL
    Cancer J; 2019; 25(4):272-281. PubMed ID: 31335391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.